- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04386434
Active for Life Assisted Living Feasibility and Acceptability Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sedentary behavior (SB) is an emerging health risk, especially for older adults, as it is associated with chronic disease, loss of function, and increased disability and frailty. Older adults in assisted living (AL) are less active than their peers living independently. Recent evidence demonstrates there are substantial health benefits from light physical activity (LPA) and the newly published Physical Activity Guidelines for Americans recommends that older adults replace SB with LPA. An intervention to increase LPA and reduce SB has potential to reduce health risks, slow functional decline and frailty, and delay residents' needs for higher-level care such as a nursing home. We propose to test the feasibility and acceptability of a self-efficacy based intervention, "Active for Life," with the goal of increasing PA and decreasing SB of AL residents.
Active for Life is a 12 week intervention. Key components include (a) exercise with functional circuit training (FCT), walking, and stretching, (b) a behavioral component with a structured self-efficacy enhancing intervention that includes self-regulation strategies, and (c) education that addresses principles of exercise, the distinct health benefits of LPA, the negative consequences of too much sedentary time, and strategies for overcoming barriers to physical activity. It is important to test the feasibility and acceptability of the intervention for AL residents because this population will be more frail than previously tested populations. The intervention has been modified to be appropriate for AL residents based on guidance from AL experts and individual interviews conducted with AL residents. We will enroll 27 participants from approximately four AL facilities. Outcomes will be measured at baseline and at conclusion of the intervention. The primary outcomes are feasibility and acceptability of the intervention, but we will also examine preliminary evidence of outcome measures of objectively-measured sedentary behavior and physical activity, self-efficacy for exercise, value of physical activity, self-rated health, physical function, anxiety, depression, pain interference, and fatigue. This study is innovative because there are no well-established evidence-based interventions to promote PA in the AL setting and none that focus on increasing LPA and decreasing SB.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan School of Nursing
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Residing in assisted living facility
- Inactive (performing moderate level activities for less than 30 min./day, 5 day/week or not performing muscle strengthening activities twice/week) or a desire to increase physical activity
- Score of at least 3 on the Mini-Cog cognitive screening
Exclusion Criteria:
- Mobility issues that prevent participation in PA, such as if they rely on a wheelchair or motorized scooter (not excluded if they require an assistive device such as a cane or walker)
- Hospitalization in the previous month
- Skin on the thigh where ActivPAL monitor would be placed is not intact (has lesions, signs of infection, rash, or skin breakdown)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active for Life
The Active Life intervention includes structured walking, functional circuit training, stretching and behavior/educational components.
|
Each intervention session will take place within the assisted living facility twice a week for 12 weeks. Sessions will begin with 5-10 minutes of walking in the hallway. Participants will be encouraged to walk at their own pace and allowed to take breaks if needed. Next, behavioral strategies based on the construct of self-efficacy from social cognitive theory and education about physical activity will be delivered. This component is scheduled between the walking and circuit training, lasts 15-20 minutes, and serves as a rest period. Circuit training will focus on strength and balance. Approximately 8 exercise stations will be set up, and the exercises performed at each station will be changed approximately every 4 weeks. The circuit training will last ~30-40 minutes, with participants moving from one station to the next at their own pace and taking breaks in between. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility: Number of participants screened
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate how many participants volunteered to be screened for participation in the study.
|
After completion of the 12 week intervention
|
Feasibility: Number of participants eligible
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate how many participants met eligibility criteria for study participation.
|
After completion of the 12 week intervention
|
Feasibility: Numbers of participants ineligible by each eligibility criterion
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will summarize reasons that participants were ineligible for study participation by adding up the number of people who don't meet each specific eligibility criterion.
|
After completion of the 12 week intervention
|
Feasibility: Number of participants who enroll
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate how many eligible participants decide to enroll in the study.
|
After completion of the 12 week intervention
|
Feasibility: Length of time for recruitment activities
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate how much time is spent to recruit the study sample.
|
After completion of the 12 week intervention
|
Feasibility: Percentage of activity sessions attended by participants
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate the percentage of activity sessions that participants attended.
|
After completion of the 12 week intervention
|
Feasibility: Participant retention rates
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will calculate retention rates of how many participants started and how many completed the study.
|
After completion of the 12 week intervention
|
Feasibility: Documentation of stated reasons for participant dropout
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will document stated reasons for dropout from the study as much as we are able.
|
After completion of the 12 week intervention
|
Feasibility: Injuries and adverse events
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will summarize any adverse events/injuries that occur during the study.
|
After completion of the 12 week intervention
|
Feasibility: Rates of missing or unusable data
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will summarize how much data are missing from baseline, mid-intervention, and post-intervention data collections.
|
After completion of the 12 week intervention
|
Feasibility: Time required to complete outcome measures
Time Frame: After completion of the 12 week intervention
|
Several measures will be used to describe the feasibility of the intervention.
We will keep record of how long each data collection session takes and calculate average length of data collection at both baseline and post-intervention.
|
After completion of the 12 week intervention
|
Acceptability: Exit interviews
Time Frame: After completion of the 12 week intervention
|
Semi-structured exit interviews will ask questions related to acceptability of the intervention, such as how participants felt about the overall intervention and its specific components, whether the time commitment was reasonable, whether assisted living staff were supportive of their participation and goals, and any suggestions for future improvements.
|
After completion of the 12 week intervention
|
Acceptability: Final acceptability scale
Time Frame: After completion of the 12 week intervention
|
This scale consists of 13 questions related to participants' overall satisfaction with the intervention and its components.
Higher score indicates greater intervention acceptability.
|
After completion of the 12 week intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time spent in sedentary behavior and physical activity
Time Frame: 7 days of data are gathered at baseline at after the 12 week intervention.
|
ActivPAL monitor will measure time spent sitting/lying, standing, and stepping for 7 consecutive days at each measurement.
|
7 days of data are gathered at baseline at after the 12 week intervention.
|
Self-efficacy for exercise
Time Frame: Measured at baseline, three weeks, and after 12 week intervention.
|
Exercise self-efficacy- 9 items.
Potential range of scores is 0 to 90.
Higher score indicates higher self-efficacy for exercise.
|
Measured at baseline, three weeks, and after 12 week intervention.
|
Value of Physical Activity
Time Frame: Measured at baseline and after 12 week intervention.
|
Single item asking "How important is physical activity in your life?" with a Likert response scale ranging from 1 to 5. Higher score will indicate greater importance of physical activity
|
Measured at baseline and after 12 week intervention.
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health
Time Frame: Measured at baseline and after 12 week intervention.
|
Physical, social, and mental health- 10 items.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low global health and higher scores indicate higher global health.
|
Measured at baseline and after 12 week intervention.
|
PROMIS Physical Functioning
Time Frame: Measured at baseline and after 12 week intervention.
|
Physical function scale- measured with computer adaptive testing.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low physical function and higher scores indicate higher physical function.
|
Measured at baseline and after 12 week intervention.
|
PROMIS Anxiety
Time Frame: Measured at baseline and after 12 week intervention.
|
General experience with anxious moods- measured with computer adaptive testing.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low anxiety and higher scores indicate higher anxiety.
|
Measured at baseline and after 12 week intervention.
|
PROMIS Depression
Time Frame: Measured at baseline and after 12 week intervention.
|
General experience with depressed moods- measured with computer adaptive testing.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low depression and higher scores indicate higher depression.
|
Measured at baseline and after 12 week intervention.
|
PROMIS Fatigue
Time Frame: Measured at baseline and after 12 week intervention.
|
General experience of fatigue- measured with computer adaptive testing.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low fatigue and higher scores indicate higher fatigue.
|
Measured at baseline and after 12 week intervention.
|
PROMIS Pain Interference
Time Frame: Measured at baseline and after 12 week intervention.
|
Extent to which pain interferes with functioning- measured with computer adaptive testing.
Scores are calculated as T-scores with a mean = 50 and standard deviation = 10.
Low scores indicate low pain interference and higher scores indicate higher pain interference.
|
Measured at baseline and after 12 week intervention.
|
Positive and Negative Social Influences on PA in Older Adults
Time Frame: Measured at baseline and after 12 week intervention.
|
Support from family and friends for being physically active.
The questionnaire has 27 items (15 items describing positive social influence and 12 items describing negative social influence).
The potential range of scores for positive social influence is 0 to 180 and the potential range of scores for negative social influence is 0 to 144.
|
Measured at baseline and after 12 week intervention.
|
Acceptability: Mid-point acceptability scale
Time Frame: Measured at 6-weeks (mid-point of intervention)
|
This scale consists of 3 questions related to acceptability of intervention delivery.
Higher score indicates greater intervention acceptability.
|
Measured at 6-weeks (mid-point of intervention)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Janet L Larson, PhD, RN, University of Michigan School of Nursing
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HUM00175558
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Loughborough UniversityBritish Heart FoundationCompletedSedentary Lifestyle | Sedentary Behavior | Diet Habit
-
Biruni UniversityCompletedSedentary Behavior | Health BehaviorTurkey
-
Eskisehir Technical UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingSedentary Lifestyle | Sedentary Behavior | Physical Activity Level
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
The University of Texas Health Science Center,...M.D. Anderson Cancer CenterRecruitingSedentary BehaviorUnited States
-
School of Health Sciences GenevaRecruiting
-
Universita di VeronaNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulNot yet recruitingSedentary BehaviorBrazil
Clinical Trials on Active for Life: Assisted Living
-
Asan Medical CenterCompletedCOPDKorea, Republic of
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Centers for Disease Control and PreventionUniversity of North CarolinaCompleted
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingOverweight/ObesityUnited States
-
Northwestern UniversityCompleted
-
University of Southern CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1United States
-
University of EdinburghUniversity of Glasgow; Chief Scientist Office of the Scottish Government; University... and other collaboratorsUnknownDepression | Coronary Heart Disease | Diabetes Mellitus Type 2United Kingdom
-
Tufts UniversityTufts Clinical and Translational Science InstituteTerminated
-
University of New MexicoNational Center for Research Resources (NCRR)Terminated
-
Centre Francois BaclesseCompletedQuality of Life | Endometrial Cancer | Chemotherapy EffectFrance